Reliv' International, Inc. (RELV) Social Stream
Featured Post From StockTwits About RELV
$RELV ASXC This is the future of surgery with Senhance. No other competitor has this kind of AI technology. Senhance will be the gold standard for surgery in the upcoming years. Minimum buyout value 2-4b+ ($30-$50 per share). https://youtu.be/dbCffQHncD0travonharris, published March 24, 2021
Other Notable StockTweets About RELV
$RELV Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On December 4, 2020, the Company issued a press release announcing an update to its ..